Studies have shown that HMGB1 exists in the early stages of pulmonary inflammation and late fibrosis, and glycyrrhizic acid inhibits the expression of HMGB1, which can slow down the progression of pulmonary inflammation and fibrosis [15]. The gene discussed is HMGB1; the disease is inflammatory response.